Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Fucoidan Exerts Anticancer Effects Against Head and Neck Squamous Cell Carcinoma In Vitro.

Blaszczak W, Lach MS, Barczak W, Suchorska WM.

Molecules. 2018 Dec 12;23(12). pii: E3302. doi: 10.3390/molecules23123302.

2.

Chondrocytes differentiated from human induced pluripotent stem cells: Response to ionizing radiation.

Stelcer E, Kulcenty K, Suchorska WM.

PLoS One. 2018 Oct 23;13(10):e0205691. doi: 10.1371/journal.pone.0205691. eCollection 2018.

3.

Effect of cellular mass on chondrogenic differentiation during embryoid body formation.

Lach MS, Kulcenty K, Jankowska K, Trzeciak T, Richter M, Suchorska WM.

Mol Med Rep. 2018 Sep;18(3):2705-2714. doi: 10.3892/mmr.2018.9272. Epub 2018 Jul 10.

4.

Forced differentiation in vitro leads to stress-induced activation of DNA damage response in hiPSC-derived chondrocyte-like cells.

Stelcer E, Kulcenty K, Rucinski M, Jopek K, Richter M, Trzeciak T, Suchorska WM.

PLoS One. 2018 Jun 4;13(6):e0198079. doi: 10.1371/journal.pone.0198079. eCollection 2018.

5.

Chondrogenic differentiation in vitro of hiPSCs activates pathways engaged in limb development.

Stelcer E, Kulcenty K, Rucinski M, Jopek K, Richter M, Trzeciak T, Suchorska WM.

Stem Cell Res. 2018 Jul;30:53-60. doi: 10.1016/j.scr.2018.05.006. Epub 2018 May 22. No abstract available.

6.

Wound fluids collected from patients after IORT treatment activates extrinsic apoptotic pathway in MCF7 breast cancer cell line.

Kulcenty KI, Piotrowski I, Zaleska K, Murawa D, Suchorska WM.

Ginekol Pol. 2018;89(4):175-182. doi: 10.5603/GP.a2018.0030.

7.

Carcinogenesis Induced by Low-dose Radiation.

Piotrowski I, Kulcenty K, Suchorska WM, Skrobała A, Skórska M, Kruszyna-Mochalska M, Kowalik A, Jackowiak W, Malicki J.

Radiol Oncol. 2017 Nov 1;51(4):369-377. doi: 10.1515/raon-2017-0044. eCollection 2017 Dec.

8.

Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review.

Dylawerska A, Barczak W, Wegner A, Golusinski W, Suchorska WM.

Med Oncol. 2017 Nov 15;34(12):197. doi: 10.1007/s12032-017-1057-4. Review.

9.

Modified methods for efficiently differentiating human embryonic stem cells into chondrocyte-like cells.

Suchorska WM, Augustyniak E, Richter M, Łukjanow M, Filas V, Kaczmarczyk J, Trzeciak T.

Postepy Hig Med Dosw (Online). 2017 Jun 19;71(0):500-509.

PMID:
28665279
10.

Gene expression profile in human induced pluripotent stem cells: Chondrogenic differentiation in vitro, part A.

Suchorska WM, Augustyniak E, Richter M, Trzeciak T.

Mol Med Rep. 2017 May;15(5):2387-2401. doi: 10.3892/mmr.2017.6334. Epub 2017 Mar 16.

11.

Gene expression profile in human induced pluripotent stem cells: Chondrogenic differentiation in vitro, part B.

Augustyniak E, Suchorska WM, Trzeciak T, Richter M.

Mol Med Rep. 2017 May;15(5):2402-2414. doi: 10.3892/mmr.2017.6335. Epub 2017 Mar 16.

12.

A feeder- and xeno-free human induced pluripotent stem cell line obtained from primary human dermal fibroblasts with epigenetic repression of reprogramming factors expression: GPCCi001-A.

Lach MS, Wroblewska JP, Augustyniak E, Kulcenty K, Suchorska WM.

Stem Cell Res. 2017 Apr;20:34-37. doi: 10.1016/j.scr.2017.02.004. Epub 2017 Feb 21.

13.

Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma.

Blaszczak W, Barczak W, Wegner A, Golusinski W, Suchorska WM.

Med Oncol. 2017 Apr;34(4):60. doi: 10.1007/s12032-017-0918-1. Epub 2017 Mar 17. Review.

14.

Comparison of the early response of human embryonic stem cells and human induced pluripotent stem cells to ionizing radiation.

Suchorska WM, Augustyniak E, Łukjanow M.

Mol Med Rep. 2017 Apr;15(4):1952-1962. doi: 10.3892/mmr.2017.6270. Epub 2017 Mar 1.

15.

Comparison of Four Protocols to Generate Chondrocyte-Like Cells from Human Induced Pluripotent Stem Cells (hiPSCs).

Suchorska WM, Augustyniak E, Richter M, Trzeciak T.

Stem Cell Rev. 2017 Apr;13(2):299-308. doi: 10.1007/s12015-016-9708-y.

16.
17.

RNA interference in head and neck oncology.

Sobecka A, Barczak W, Suchorska WM.

Oncol Lett. 2016 Nov;12(5):3035-3040. Epub 2016 Sep 2.

18.

Genetic stability of pluripotent stem cells during anti-cancer therapies.

Suchorska WM, Augustyniak E, Łukjanow M.

Exp Ther Med. 2016 Mar;11(3):695-702. Epub 2016 Jan 13.

19.

Hyper-interleukin-11 novel designer molecular adjuvant targeting gp130 for whole cell cancer vaccines.

Suchorska WM, Dams-Kozlowska H, Kazimierczak U, Wysocki PJ, Mackiewicz A.

Expert Opin Biol Ther. 2011 Dec;11(12):1555-67. doi: 10.1517/14712598.2011.627852. Epub 2011 Oct 14. Review.

PMID:
21995459

Supplemental Content

Loading ...
Support Center